Navigating Clinical & Post-Approval Considerations for Inflammasome Inhibitors with Diverse Uses and Future Implications
Time: 9:30 am
day: Day 2
Details:
- Gain insights into the advanced stage of development for novel inflammasome inhibitors
- Examine the broader implications of inflammasome inhibitor approvals, including offlabel usage considerations, insurance coverage challenges, and their impact on existing treatment paradigm
- Explore how the approval and widespread adoption of inflammasome inhibitors may disrupt traditional therapeutic approaches, particularly in comparison to corticosteroids
